Back
Rate this talk
Your peers rated this 4 stars
7-minute watch | Talk 2 of 7

ICML: Improving outcomes in R/R DLBCL: Learning from challenging cases

Welcome, introduction and challenges in R/R DLBCL: Overview

Prof. Marie José Kersten
SYMPOSIUM
ICML

Prof. Marie José Kersten
Amsterdam University Medical Centers, Amsterdam, Netherlands

Prof. Marie José Kersten, Amsterdam University Medical Centers, Amsterdam, Netherlands, introduces the symposium which focuses on improving outcomes in R/R DLBCL

Read more

Talks in this series

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch | Talk 2 of 7
Welcome, introduction and challenges in R/R DLBCL: Overview
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch

Welcome, introduction and challenges in R/R DLBCL: Overview

Prof. Marie José Kersten

Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch | Talk 2 of 7
Welcome, introduction and challenges in R/R DLBCL: Overview
Prof. Marie José Kersten
Prof. Marie José Kersten presents at ICML (Improving outcomes in R_R DLBCL)
7-minute watch

Welcome, introduction and challenges in R/R DLBCL: Overview

Prof. Marie José Kersten

Interested in this topic?

Find more like this

  This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In the United Kingdom, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.